• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA lnc-LOC645166 通过 NF-κB/GATA3 轴促进乳腺癌中阿霉素耐药。

Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer.

机构信息

Department of Oncology, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan 523000, Guangdong Province, P.R. China.

Clinical Research Center, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan 523000, Guangdong Province, P.R. China.

出版信息

Aging (Albany NY). 2020 May 27;12(10):8893-8912. doi: 10.18632/aging.103012.

DOI:10.18632/aging.103012
PMID:32461377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7288957/
Abstract

Chemoresistance remains a significant obstacle for effective adriamycin (ADR) treatment in breast cancer. Recent efforts have revealed that long noncoding RNAs (lncRNAs) play a crucial role in cancer biology, including chemoresistance. We identified the lncRNA LOC645166 was upregulated in adriamycin resistant-breast cancer cells by Microarray analysis, which was further confirmed in the tissues of nonresponsive patients by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), western blotting, and immunohistochemical assays. Downregulation of lncRNA LOC645166 increased cell sensitivity to adriamycin both and . In contrast, upregulation of lncRNA LOC645166 strengthened the tolerance of breast cancer cells to adriamycin. Chromatin immunoprecipitation (ChIP) and RNA binding protein immunoprecipitation (RIP) demonstrated that lncRNA LOC645166 could increase the expression of GATA binding protein 3 (GATA3) via binding with nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), leading to the activation of STAT3 and promoting chemoresistance in breast cancer. Together, the present study suggested that lncRNA LOC645166 mediated adriamycin chemoresistance in breast cancer by regulating GATA3 via NF-κB.

摘要

化疗耐药性仍然是乳腺癌中阿霉素(ADR)有效治疗的重大障碍。最近的研究表明,长非编码 RNA(lncRNA)在癌症生物学中发挥着关键作用,包括化疗耐药性。我们通过微阵列分析发现 lncRNA LOC645166 在阿霉素耐药乳腺癌细胞中上调,通过逆转录-定量聚合酶链反应(RT-qPCR)、Western blot 和免疫组织化学检测进一步在无反应患者的组织中得到证实。lncRNA LOC645166 的下调增加了细胞对阿霉素的敏感性。相比之下,lncRNA LOC645166 的上调增强了乳腺癌细胞对阿霉素的耐受性。染色质免疫沉淀(ChIP)和 RNA 结合蛋白免疫沉淀(RIP)表明,lncRNA LOC645166 可以通过与核因子 kappa-轻链增强子的 B 细胞激活因子(NF-κB)结合,增加 GATA 结合蛋白 3(GATA3)的表达,从而激活 STAT3 并促进乳腺癌的化疗耐药性。总之,本研究表明,lncRNA LOC645166 通过 NF-κB 调节 GATA3 介导乳腺癌的阿霉素耐药性。

相似文献

1
Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer.长链非编码 RNA lnc-LOC645166 通过 NF-κB/GATA3 轴促进乳腺癌中阿霉素耐药。
Aging (Albany NY). 2020 May 27;12(10):8893-8912. doi: 10.18632/aging.103012.
2
A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance.一个 hMTR4-PDIA3P1-miR-125/124-TRAF6 调控轴及其在 NF-κB 信号和化疗耐药中的功能。
Hepatology. 2020 May;71(5):1660-1677. doi: 10.1002/hep.30931. Epub 2019 Oct 23.
3
Down-Regulation of LOC645166 in T Cells of Ankylosing Spondylitis Patients Promotes the NF-κB Signaling Decreasingly Blocking Recruitment of the IKK Complex to K63-Linked Polyubiquitin Chains.强直性脊柱炎患者 T 细胞中 LOC645166 的下调促进 NF-κB 信号通路,从而减少 IKK 复合物募集到 K63 连接的多聚泛素链。
Front Immunol. 2021 Feb 25;12:591706. doi: 10.3389/fimmu.2021.591706. eCollection 2021.
4
Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.Linc00518通过调控乳腺癌中的miR-199a/MRP1轴促进多药耐药。
Cell Physiol Biochem. 2018;48(1):16-28. doi: 10.1159/000491659. Epub 2018 Jul 12.
5
Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.m6A 甲基转移酶 METTL3 介导的 MALAT1/E2F1/AGR2 轴对乳腺癌阿霉素耐药的影响。
J Biochem Mol Toxicol. 2022 Jan;36(1):e22922. doi: 10.1002/jbt.22922. Epub 2021 Dec 28.
6
Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.核因子-κB 在 MCF-7/Adr 细胞中阿霉素细胞药代动力学中的关键作用:与 20(S)-人参皂苷 Rh2 协同作用的潜在机制。
Drug Metab Dispos. 2012 Oct;40(10):1900-8. doi: 10.1124/dmd.112.045187. Epub 2012 Jun 27.
7
Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells.人乳腺癌细胞中与化疗耐药相关的长非编码 RNA 表达谱。
Mol Med Rep. 2018 Jul;18(1):243-253. doi: 10.3892/mmr.2018.8942. Epub 2018 Apr 27.
8
Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1.长链非编码 RNA H19 通过靶向 PARP1 调节 MCF-7 细胞的增殖和阿霉素耐药性。
Bioengineered. 2020 Dec;11(1):536-546. doi: 10.1080/21655979.2020.1761512.
9
LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer.长链非编码RNA DDX11-AS1通过LIN28A介导的自噬相关蛋白12(ATG12)信使核糖核酸稳定化促进乳腺癌的化疗耐药性。
Pharmacology. 2023;108(1):61-73. doi: 10.1159/000527222. Epub 2022 Nov 16.
10
MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.微小RNA-29a通过PTEN/AKT/GSK3β信号通路导致乳腺癌细胞对阿霉素耐药。
Gene. 2016 Nov 15;593(1):84-90. doi: 10.1016/j.gene.2016.08.016. Epub 2016 Aug 11.

引用本文的文献

1
CAF-EVs carry lncRNA MAPKAPK5-AS1 into hepatocellular carcinoma cells and promote malignant cell proliferation.癌相关成纤维细胞衍生的细胞外囊泡将长链非编码RNA MAPKAPK5-AS1转运至肝癌细胞中并促进恶性细胞增殖。
Commun Biol. 2024 Dec 30;7(1):1711. doi: 10.1038/s42003-024-07428-3.
2
The regulatory relationship between transcription factor STAT3 and noncoding RNA.转录因子 STAT3 与非编码 RNA 的调控关系。
Cell Mol Biol Lett. 2024 Jan 3;29(1):4. doi: 10.1186/s11658-023-00521-1.
3
Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.

本文引用的文献

1
Single-Cell Analysis Reveals a Preexisting Drug-Resistant Subpopulation in the Luminal Breast Cancer Subtype.单细胞分析揭示了腔面乳腺癌亚型中预先存在的耐药亚群。
Cancer Res. 2019 Sep 1;79(17):4412-4425. doi: 10.1158/0008-5472.CAN-19-0122. Epub 2019 Jul 9.
2
The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers.长链非编码 RNA BORG 促进三阴性乳腺癌的存活和化疗耐药性。
Oncogene. 2019 Mar;38(12):2020-2041. doi: 10.1038/s41388-018-0586-4. Epub 2018 Nov 22.
3
Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling.
乳腺癌化疗耐药性:lncRNA 调控作用的新见解。
Int J Mol Sci. 2023 Nov 2;24(21):15897. doi: 10.3390/ijms242115897.
4
Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer.长链非编码RNA参与癌症多柔比星耐药性的研究进展
Front Pharmacol. 2023 Sep 15;14:1243934. doi: 10.3389/fphar.2023.1243934. eCollection 2023.
5
Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway.乳腺癌中的阿霉素耐药是通过FABP5/PPARγ和CaMKII信号通路的激活介导的。
Front Pharmacol. 2023 Jul 19;14:1150861. doi: 10.3389/fphar.2023.1150861. eCollection 2023.
6
The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer.长链非编码 RNA 的临床实用性及其作为乳腺癌分子标志物的应用。
Int J Mol Sci. 2023 Apr 18;24(8):7426. doi: 10.3390/ijms24087426.
7
Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer.长链非编码 RNA 在乳腺癌中的作用和机制。
Int J Mol Sci. 2022 Dec 21;24(1):89. doi: 10.3390/ijms24010089.
8
Long Intergenic Non-Protein Coding RNA 173 in Human Cancers.人类癌症中的长链基因间非编码RNA 173
Cancers (Basel). 2022 Nov 30;14(23):5923. doi: 10.3390/cancers14235923.
9
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications.癌症耐药性中的非编码RNA:潜在机制与临床应用
Front Oncol. 2022 Aug 17;12:951864. doi: 10.3389/fonc.2022.951864. eCollection 2022.
10
The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer.长链非编码RNA介导的多药耐药机制及长链非编码RNA在乳腺癌中的临床应用前景
Cancers (Basel). 2022 Apr 23;14(9):2101. doi: 10.3390/cancers14092101.
异甘草素通过靶向 miR-301b/LRIG1 信号通路抑制人黑色素瘤生长。
J Exp Clin Cancer Res. 2018 Aug 6;37(1):184. doi: 10.1186/s13046-018-0844-x.
4
Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.长链非编码 RNA MEG3 的上调抑制膀胱癌细胞的迁移和侵袭,并增强顺铂化疗敏感性。
Neoplasma. 2018 Nov 15;65(6):925-932. doi: 10.4149/neo_2018_180125N55. Epub 2018 Jun 18.
5
Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells.跨膜 TNF-α 促进乳腺癌细胞的化疗耐药性。
Oncogene. 2018 Jun;37(25):3456-3470. doi: 10.1038/s41388-018-0221-4. Epub 2018 Mar 21.
6
Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.miR-589-5p 通过维持肝癌细胞干性促进化疗耐药性的发生,其作用机制与 STAT3 信号通路有关。
Cancer Lett. 2018 Jun 1;423:113-126. doi: 10.1016/j.canlet.2017.11.031. Epub 2017 Nov 28.
7
The long noncoding RNA SNHG1 promotes tumor growth through regulating transcription of both local and distal genes.长链非编码RNA SNHG1通过调控局部和远端基因的转录促进肿瘤生长。
Oncogene. 2017 Dec 7;36(49):6774-6783. doi: 10.1038/onc.2017.286. Epub 2017 Aug 21.
8
Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.对癌症化疗药物的耐药性由关键的微小RNA调节因子决定。
Am J Cancer Res. 2017 Jun 1;7(6):1350-1371. eCollection 2017.
9
Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.反义长链非编码 RNA FOXC2-AS1 通过增加 FOXC2 的表达促进骨肉瘤对阿霉素的耐药性。
Cancer Lett. 2017 Jun 28;396:66-75. doi: 10.1016/j.canlet.2017.03.018. Epub 2017 Mar 16.
10
LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.长链非编码RNA HULC通过稳定沉默调节蛋白1触发自噬并减弱肝癌细胞的化学敏感性。
Oncogene. 2017 Jun 22;36(25):3528-3540. doi: 10.1038/onc.2016.521. Epub 2017 Feb 6.